EATRIS is looking to recruit two high quality individuals for the positions of Business Development Manager and Communications Manager ... Read more
Translational medicine is the transformation of laboratory research outcomes into new ways to diagnose and treat patients to improve the health of millions of people worldwide. It takes promising biomedical innovations 'from bench to bedside' and bridges clinical needs from bedside to bench.
EATRIS provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations. EATRIS comprises over 70 leading academic institutions across Europe, each renowned for its individual and high-end research facilities.
This infrastructure provides the following advantages:
- Single point of access to the right expertise and facilities
- Expedites the development process
- Access to large and diverse clinical patient cohorts
EATRIS Co-initiates Global Network Collaboration
EATRIS Developed Collaboration to Accelerate the Validation of New Thyroid Cancer DiagnosticRead more
The European Medicines Agency (EMA) has adopted a landmark policy to take effect on 1 January 2015.Read more
Building bridges in translational medicine
27th and 28th May 2015, AmsterdamRead more
Collaboration with EARL to establish a Zirconium PET/CT accreditation programme ...Read more
A new 'pilot' collaboration with the Medicines Evaluation Board of The Netherlands ...Read more
An interview with Tom Saylor on the roles of and challenges facing SMEs in drug development.Read more
Shedding a light in the dark
EATRIS has produced an information sheet ‘PET IMAGING OF NEW DRUGS: SHEDDING LIGHT IN THE DARK’
The importance of the role of biobanking within biomedical research is recognized through the collaboration between EATRIS-ERIC and BBMRI-ERIC. Read more
EATRIS enters framework agreement with Roche to access Europe-wide network of translational researchers.
The Patients Network for Medical Research and Health and EATRIS ERIC have signed a letter of intent .... read more
In November 2013 the European Commission approved the creation of a new European research infrastructure - EATRIS ERIC ... read more
The EATRIS Board of National Directors held their bi-annual meeting in April 2014 ... Marián Hajdúch elected as the new Chair ... read more
Cancer specialist, and founder of the VUmc Cancer Center Amsterdam , Bob Pinedo receives prestigious US award .... read more
Conference Report - New Horizons for Vaccine Research and Innovation, Brussels, Belgium, 12-13 March 2014 .... read more
European Commission supports project that will define a new vision for vaccine research in Europe and proposes strategies for its achievement ... read more
The IPROVE consortium launched its first consultation workshop dedicated to vaccine SME needs as part of the IPROVE project .... read more
Innovation for Health - Shaping the future of healthcare together, the Netherlands.
1st Danish Symposium on Biomarkers and the Implementation of Personalized Medicine to the Clinic, Copenhagen.
8th Vaccine & ISU Congress The 8th annual Vaccine and ISU Congress will take place over 3 days in Philadelphia, USA.
27th Annual EANM Congress, Gothenburg, Sweden.